PriceTargets.com logo

NewGenIvf Group - NIVF Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 1
  • Breakdown:
  • 1 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$1.49 As of 12/4/2025 05:00 PM ET
▲ +0.17 (12.88%)

This chart shows the closing price for NIVF by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New NewGenIvf Group Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for NIVF and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for NIVF

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 1 analysts offering 12 month price targets for NewGenIvf Group in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $1.49.

This chart shows the closing price for NIVF for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Sell

The current consensus among 1 investment analysts is to sell stock in NewGenIvf Group.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/13/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/11/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
11/5/2025
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings
Ratings as of
12/5/2025

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 1 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/31/2025Weiss RatingsReiterated RatingSell (D) ➝ Sell (D)
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
(Data available from 12/5/2020 forward)

News Sentiment Rating

0.40 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/9/2025
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
6/8/2025
  • 4 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/8/2025
  • 2 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/7/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/6/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/6/2025
  • 2 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 2 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025

Current Sentiment

  • 2 very positive mentions
  • 6 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

NewGenIvf Group logo
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company was founded by Siu Wing Fung and Fong Hei Yue on January 16, 2019 and is headquartered in Bangkok, Thailand.
Read More

Today's Range

Now: $1.49
Low: $1.26
High: $1.49

50 Day Range

MA: $5.00
Low: $1.32
High: $10.13

52 Week Range

Now: $1.49
Low: $1.21
High: $2,735.00

Volume

307,171 shs

Average Volume

691,325 shs

Market Capitalization

$879.10 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of NewGenIvf Group?

The following Wall Street research analysts have issued stock ratings on NewGenIvf Group in the last twelve months: Weiss Ratings.
View the latest analyst ratings for NIVF.

What is the current price target for NewGenIvf Group?

0 Wall Street analysts have set twelve-month price targets for NewGenIvf Group in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for NewGenIvf Group in the next year.
View the latest price targets for NIVF.

What is the current consensus analyst rating for NewGenIvf Group?

NewGenIvf Group currently has 1 sell rating from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe NIVF will underperform the market and that investors should sell shares of NewGenIvf Group.
View the latest ratings for NIVF.

What other companies compete with NewGenIvf Group?

Other companies that are similar to NewGenIvf Group include Mangoceuticals, Concord Medical Services, Biorestorative Therapies, BioNexus Gene Lab and Aclarion. Learn More about companies similar to NewGenIvf Group.

How do I contact NewGenIvf Group's investor relations team?

NewGenIvf Group's physical mailing address is LEVEL 39 MARINA BAY FINANCIAL CENTRE TOWER 2 10 MARINA BOULEVARD, SINGAPORE U0, 018983. The company's listed phone number is 65-6818-5796 and its investor relations email address is [email protected]. The official website for NewGenIvf Group is newgenivf.com. Learn More about contacing NewGenIvf Group investor relations.